AstraZeneca's China Business Under Spotlight Amid Fraud Case

Seeking Alpha26分前

Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say

Benzinga04:09

Arcus Says Gilead-partnered Cancer Therapy Cut Death Risk by 36%

Seeking Alpha03:38

Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity

Benzinga02:32

Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?

Benzinga01:58

10 Health Care Stocks Whale Activity In Today's Session

Benzinga01:35